Discover 1,918 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Georgia presents extensive opportunities for healthy volunteers looking to participate in paid studies and individuals with specific health conditions alike. Research hubs in major cities like Atlanta, Augusta, and Savannah are actively recruiting participants, providing access to emerging therapies and top-tier medical care.
Filter
1
Filter results
Results: 1,918
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
for
Plasma Cell Myeloma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT05208307
Phase 2, Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Hematological Malignancies
Location: New York NY, Rochester NY, Hollywood FL, Atlanta GA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04634552
Phase 2, Recruiting
Opioid-Sparing Joint Replacement
for
Pain Management, Opioid Consumption
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT07348627
Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
for
Solid Tumor
Location: New York NY, Tampa FL, Augusta GA, Chicago IL,
Sponsor: Eisai Inc.
Sex: All
Age: 18+
Code: NCT04300556
Phase 1, Phase 2, Recruiting
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
for
HIV Infections
Location: Washington DC, Miami FL, Tampa FL, Atlanta GA,
Sponsor: ViiV Healthcare
Sex: All
Age: 6 - 12
Code: NCT05674656
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
for
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2,
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Lauren Moore
Sex: All
Age: 6+
Code: NCT01060371
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Scarborough ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
for
Hematologic Malignancies,
Location: Boston MA, Hackensack NJ, Baltimore MD, Chapel Hill NC,
Sponsor: Pulmotect, Inc.
Sex: All
Age: 18+
Code: NCT06665100
Phase 2, Recruiting
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
for
Pancreatic Cancer
Location: Lake Success NY, Millburn NJ, Montreal, Baltimore MD,
Sponsor: University of Louisville
Sex: All
Age: 18+
Code: NCT02674100
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)